Lapatinib is classified as a signal transduction inhibitor - tyrosine kinase inhibitor, inhibitor of EGFR and HER2. Lapatinib is marketed as Tykerb and is used in the treatment of metastatic breast cancer that is HER-2 positive. The drug may also be used in combination with other chemotherapy drugs or for the treatment of other cancers.
Related categories 1
Sites 1
Loading new listings for you to review...
- RxList: Tykerb (Lapatinib) Provides medication description and drug information including side effects, interactions, and patient labeling.